Table 3 Completion rates and scores for routinely collected and patient-reported outcome measures
Outcome measure | Intervention (n = 95) | Control (n = 66) | Overall (n = 161) | |||
|---|---|---|---|---|---|---|
n(%) | Mean (SD) | n(%) | Mean (SD) | n(%) | Mean (SD) | |
Emergency readmissions | ||||||
30 days | 87 (91.6%) | 0.2 (0.4) | 61 (92.4%) | 0.2 (0.6) | 148 (91.9%) | 0.2 (0.5) |
60 days | 87 (91.6%) | 0.3 (0.6) | 61 (92.4%) | 0.4 (0.7) | 148 (91.9%) | 0.3 (0.6) |
90 days | 87 (91.6%) | 0.4 (0.6) | 61 (92.4%) | 0.5 (0.7) | 148 (91.9%) | 0.4 (0.7) |
EQ5D-5L | ||||||
Baseline | 95 (100.0%) | 0.512 (0.3) | 66 (100.0%) | 0.441 (0.3) | 161 (100.0%) | 0.483 (0.3) |
5 days | 68 (71.6%) | 0.495 (0.3) | 48 (72.7%) | 0.506 (0.3) | 116 (72.0%) | 0.499 (0.3) |
30 days | 51 (53.7%) | 0.512 (0.3) | 40 (60.6%) | 0.484 (0.3) | 91 (56.5%) | 0.500 (0.3) |
90 days | 11 (11.6%) | 0.416 (0.4) | 16 (24.2%) | 0.587 (0.3) | 27 (16.8%) | 0.517 (0.3) |
EQ5D VAS | ||||||
Baseline | 95 (100.0%) | 50.1 (21.1) | 66 (100.0%) | 56.2 (20.0) | 161 (100.0%) | 52.6 (20.8) |
5 days | 69 (72.6%) | 58.2 (18.0) | 47 (71.2%) | 53.7 (23.3) | 116 (72.0%) | 56.4 (20.3) |
30 days | 53 (55.8%) | 60.5 (20.6) | 39 (59.1%) | 60.2 (20.0) | 92 (57.1%) | 60.4 (20.2) |
90 days | 11 (11.6%) | 58.2 (20.3) | 16 (24.2%) | 67.8 (17.9) | 27 (16.8%) | 63.9 (19.1) |
PACT-M | ||||||
5 days | 62 (65.3%) | 50.8 (9.2) | 38 (57.6%) | 49.5 (9.6) | 100 (62.1%) | 50.3 (9.3) |
30 days | 45 (47.4%) | 54.4 (8.3) | 34 (51.6%) | 53.1 (9.0) | 79 (49.1%) | 53.8 (8.6) |
90 days | 9 (9.5%) | 51.3 (8.3) | 11 (16.7%) | 57.5 (6.6) | 20 (12.4%) | 54.7 (7.9) |
CTM-3 | ||||||
5 days | 63 (66.3%) | 68.2 (18.6) | 43 (65.2%) | 64.0 (17.5) | 106 (65.8%) | 66.5 (18.2) |
30 days | 45 (47.4%) | 67.5 (18.5) | 33 (50%) | 63.1 (17.0) | 78 (48.4%) | 65.7 (17.9) |
90 days | 11 (11.6%) | 68.7 (19.8) | 13 (19.7%) | 63.2 (18.9) | 24 (14.9%) | 65.7 (19.1) |